Compound 468
Identifiers
- Canonical SMILES:
C[C@H]1CN(C[C@@H](C)N1C(=O)c1ccccc1)C(=O)C(=O)c1c[nH]c2cccc(F)c12
- IUPAC name:
1-(4-benzoyl-3,5-dimethylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione
- InChi:
InChI=1S/C23H22FN3O3/c1-14-12-26(13-15(2)27(14)22(29)16-7-4-3-5-8-16)23(30)21(28)17-11-25-19-10-6-9-18(24)20(17)19/h3-11,14-15,25H,12-13H2,1-2H3/t14-,15+
- InChiKey:
XSALDNVGZSFDHK-GASCZTMLSA-N
External links
45485511 |
CHEMBL585152 |
24642169 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 7.32 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 407.16 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 3.13 | |||
TPSA | 73.48 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6892 | Talmapimod | DB05412 | |
0.6222 | LY-517717 | DB05713 | |
0.6131 | Pruvanserin | DB13094 | |
0.6000 | N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID | DB07952 | |
0.5969 | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | DB07953 | |
0.5923 | Indoramin | DB08950 | |
0.5646 | Macimorelin | DB13074 | |
0.5608 | LTX-315 | DB12748 | |
0.5608 | Gramicidin D | DB00027 | |
0.5533 | TC-6987 | DB14854 | |
0.5500 | N-(indole-3-acetyl)-L-aspartic acid | DB07951 | |
0.5460 | Rucaparib | DB12332 | |
0.5440 | N-acetylserotonin | DB04275 | |
0.5431 | Indoleacetamide | DB08652 | |
0.5430 | Indibulin | DB06169 |